has been associated with improved survival following a heart attack in humans. It is still unclear how exercise protects the heart, but it is apparent that endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) play a role.
cardiovascular disease. 1 Exercise also consistently provides sustainable protection against myocardial infarction in animal models 2, 3 and is associated with improved survival following ischemic insults in humans. 4 The acute cardioprotective effects of exercise have been attributed to an increase in a number of classical preconditioning molecules, such as catalase, heat shock proteins (HSPs), and adenosine-5Јtriphosphate (ATP)-sensitive potassium channels. 3 Interestingly, the cardioprotective effects of exercise are not confined to the period of exercise, as it has been reported that protection is sustained against experimental myocardial ischemia-reperfusion (MI/R) injury for as long as 9 days after the cessation of the training. 2 The mechanism or mechanisms responsible for this sustained protection are currently not known, but it is known that HSPs and catalase do not play a role since their upregulation wanes by 7 to 9 days, suggesting that some other cardioprotective molecule or molecules are responsible for this sustained protection. 2 Previous studies have suggested a role for endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) in exercisemediated cardioprotection, as it has been reported that plasma levels of the NO metabolites, nitrite and nitrosothiols, increase during exercise in both rodents and humans. 3, 5 Nitrite represents a critically important storage reservoir of NO in blood and tissues that can readily be reduced to NO and nitrosothiols during ischemia or hypoxia. 6 The circulating levels of both metabolites directly regulate their tissue stor-age, 7 and increasing the cardiac levels of both nitrite and nitrosothiols is an effective cardioprotective strategy. 8, 9 On the basis of this evidence, one can speculate that increasing the levels of NO metabolites during exercise may contribute to its cardioprotective effects. However, it is currently not known whether exercise can augment the cardiac levels of NO metabolites.
An additional question that remains to be fully answered relates to the molecular mechanisms that lead to the activation of eNOS during exercise. Recently, the ␤ 3 -adrenergic receptor (␤ 3 -AR) has emerged as a potential target for the treatment of cardiovascular diseases including hypertension, acute MI, and heart failure. 10 This is partially related to the evidence indicating that its stimulation increases eNOS activity and NO bioavailability. 11 During exercise, there is an increase in ␤ 3 -AR stimulus (ie, catecholamines), 12 making the ␤ 3 -AR a possible source for eNOS activation. However, the role that ␤ 3 -ARs play in mediating the cardioprotective effects of exercise is currently unknown.
To address these issues, we examined the protective effects of voluntary exericise (VE) training in an established in vivo mouse model of MI/R injury. Specifically, we investigated whether NO metabolites formed during exercise were stored in the heart and whether they contributed to the sustained cardioprotective effects of exercise. Additionally, we investigated the role that ␤ 3 -ARs play in mediating the cardioprotective effects of exercise.
Methods

Animals
Male C57BL6/J mice (Jackson Labs, Bar Harbor, ME; 8 to 10 weeks of age) were utilized. The eNOS deficient mice (eNOS Ϫ/ Ϫ ; 8 to 10 weeks of age) on a C57BL6/J background 13 and ␤ 3 -adrenergic receptor deficient (␤ 3 -AR Ϫ/ Ϫ ; 8 to 10 weeks of age) mice, 14 as well as littermate controls, were also utilized. The ␤ 3 -AR Ϫ/ Ϫ mice were developed on a FVB background and backcrossed 9 generations to a C57BL6/J background. All experimental procedures were approved by the Institute for Animal Care and Use Committee at Emory University School of Medicine and conformed to the Guide for the Care and Use of Laboratory Animals, published by the National Institutes of Health (NIH Publication No. 86-23, revised 1996), and with federal and state regulations.
Subjects and Study Procedures
All procedures with human subjects were approved by the Institutional Review Board (Human Research Committee) of the University of Colorado at Boulder. The nature, benefits, and risks of the study were explained to the volunteers, and their written informed consent was obtained before participation. A total of 23 healthy young (ages 18 to 31 years) men were studied: 16 non-exercise-trained individuals and 7 endurance athletes. The nonexercise-trained subjects had performed no regular exercise for Ն2 years, whereas the trained endurance athletes performed Ͼ3 sessions per week of vigorous aerobic-endurance exercise for Ն2 years.
Voluntary Exercise Protocol
Mice were placed in custom-designed cages fitted with running wheels (Mini Mitter, Bend, OR) for a period up to 4 weeks. Running distances were monitored daily. After the exercise-training period, the running wheel was removed from the cage and the mice were allowed to rest for a 24-hour, 1-week, or 4-week period before further experimentation was conducted.
Myocardial Ischemia-Reperfusion (I/R) Protocol and Myocardial Injury Assessment
Surgical ligation of the left coronary artery (LCA), myocardial infarct size determination, and troponin-I measurements were performed, similar to methods described previously. 15
Western Blot Analysis
Western blot analysis was performed as described previously. 15
Analysis of Nitrite, Nitrate, and Nitrosothiols
Nitrite and nitrate concentrations were quantified by ion chromatography (ENO20 Analyzer, Eicom, Dayton, OH). Tissue nitrosothiol compounds were quantified using group-specific reductive denitrosation by iodine-iodide with subsequent detection of the NO liberated by gas-phase chemiluminescence. All NO analysis procedures have been previously described in detail. 8
Analysis of Catecholamine Levels
Catecholamines were measured in blood samples taken from mice using the Bi-CAT Elisa (ALPCO, Salem, NH) according to the manufacturer's instructions.
Statistical Analysis
All the data in this study are expressed as meanϮstandard error (SEM). Differences in data between the groups were compared using Prism 4 (GraphPad Software, Inc., La Jolla, CA) with Student paired 2-tailed t test, 1-way analysis of variance (ANOVA), or 2-way ANOVA (comparison of results from experiments using eNOS Ϫ/ Ϫ and ␤ 3 -AR Ϫ/ Ϫ mice). For the 1-way and 2-way ANOVAs, if a significant variance was found, the Tukey or Bonferroni test was used as the post hoc analysis. A probability value less than 0.05 was considered statistically significant.
Results
VE Training Reduces Infarct Size Following MI/R Injury
To determine whether VE training attenuated myocardial injury following myocardial I/R, we housed groups of mice in Figure  1B and 1C). We next evaluated whether the cardioprotective effects of VE training could be maintained after the mice stopped exercising. For these experiments, mice were allowed to exercise for 4 weeks (average running distance of 7.3Ϯ0.2 km/d, Online Figure I ). At the end of the training period, the mice were removed from the cages for a period of 1 week (VE 4 weeksϩ1 week SED) and then subjected to 45 minutes of left coronary artery occlusion followed by 24 hours of reperfusion. The VE 4 weeksϩ1 week SED mice displayed a 30% reduction (PϽ0.01 versus SED; Figure 1B ) in INF in relation to the AAR and a 37% reduction (PϽ0.05 versus SED; Figure 1C ) in circulating troponin-I levels. This demonstrates that VE training provides significant cardioprotection against I/R injury for at least 1 week following the cessation of the training.
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VE Training Increases CuZnSOD Expression and Alters the Phosphorylation Status of AMPK
We next investigated whether VE training altered the expression of several cardioprotective signaling molecules pur-ported to play a role in mediating exercise-induced cardioprotection. Western blot analysis ( Figure 2 ) revealed that the expression of HSP70 remained unchanged in the hearts of mice following VE training when compared with SED mice. However, a significant increase in CuZnSOD was observed in the hearts of the VE 4-week group (PϽ0.05 versus SED), but not in the hearts of the VE 4 weeksϩ1 week SED group. AMP-activated protein kinase (AMPK) is another cardioprotective signaling molecule that is activated by exercise. 16 Western blot analysis revealed ( Figure 2 ) that VE significantly increased the phosphorylation of AMPK at Thr172 in the hearts of the VE 4-week group (PϽ0.05 versus SED), but not in the hearts of the VE 4 weeksϩ1 week SED group.
VE Training Alters the Phosphorylation Status of eNOS and Increases Circulating and Cardiac NO Metabolite Levels
We next studied the effects of VE on eNOS expression and phosphorylation status. For these experiments, we exploited phosphorylation site-specific antibodies to probe immunoblots prepared from collected heart tissue. VE training promoted a significant increase ( Figure 3 ) in the phosphorylation of eNOS at serine residue 1177 (eNOS-P Ser1177 ; phosphorylation here increases enzyme activity; PϽ0.01 versus SED). VE training also promoted the dephosphorylation of eNOS at threonine residue 497 (eNOS-P Thr495 ; phosphorylation here inhibits the enzyme activity; PϽ0.05 versus SED). Importantly, the alterations in the phosphorylation status of eNOS (especially eNOS-P Ser1177 ) were still present 1 week after the end of the 4-week VE training period (PϽ0.05 versus SED). No changes in the expression of total eNOS were noted in either of the VE groups. Additionally, the expression of iNOS and nNOS remained unchanged in response to VE training ( Figure 3A , 3E, and 3F). Exercise has been associated with increasing plasma nitrite levels, 5, 16, 17 but it is not known whether exercise increases nitrite levels in the heart. Because we have previously demonstrated that increasing nitrite levels in the heart results in cardioprotection, 8 we evaluated the effects of exercise training on the levels of nitrite, nitrate, and nitrosothiols (RXNO and RSNO) in the plasma and heart. As shown in Figure 4A through 4F, a significant increase in the levels of nitrite and nitrosothiols were observed in the plasma and hearts of the VE 4-week group when compared with the SED group. Importantly, these elevations were still present 1 week after the end of the training period. Interestingly, plasma and heart nitrate levels were only significantly increased 1 week after the end of the training period (PϽ0.05 versus SED). These results suggest that NO metabolites may be responsible for the sustained cardioprotective effects of VE training, given that nitrite, nitrate, and nitrosothiols have all been shown to provide cardioprotection during myocardial ischemia by increasing NO levels and signaling. 8, 9, 18 We next investigated whether eNOS was critical for the cardioprotection afforded by VE training. Mice deficient in eNOS (eNOS Ϫ/ Ϫ ) were subjected to 4 weeks of VE training followed by MI/R ( Figure 4G ). Analysis revealed that VE training did not abrogate myocardial infarct size in eNOS Ϫ/ Ϫ mice (pϭN.S. [not significant] versus SED), suggesting that eNOS plays an important a role in the cardioprotective actions of VE. Additionally, the eNOS Ϫ/ Ϫ mice did not exercise to the same extent as the C57BL/6J wild-type mice exercised (Online Figure I 
VE Increases the Expression of eNOS and Increases the Levels of NO Metabolites in the Skeletal Muscle
Because VE involves changes in blood flow in active muscles, it is conceivable that the circulating levels of NO metabolites are derived from additional sources other than the heart. Therefore, we evaluated whether VE could alter the expression of eNOS in another working muscle, the gastrocnemius. As is shown in Online Figure II , the expression of eNOS was found to be significantly increased at the end of the 4-week training period (VE 4 weeks; PϽ0.01 versus SED), but had returned to control levels 1 week after the cessation of exercise (VE 4 weeksϩ1 week SED). We also found that there was no difference in the expression of eNOS-P Ser1177 in either group of exercised mice when the expression was compared with the expression of total eNOS. However, there was a significant increase in eNOS-P Ser1177 in the VE 4-week group when the expression was compared with the expression of ␣-tubulin (PϽ0.05 versus SED), suggesting that there was more eNOS-P Ser1177 after VE. Additionally, a significant decrease in the expression of eNOS-P Thr495 in the gastrocnemius of the VE 4-week group (PϽ0.05 versus SED), but not the VE 4 weeksϩ1 week SED group was observed. VE also significantly increased the levels of nitrite and nitrosothiols in the skeletal muscle of the VE 4-week group (Online Figure III; PϽ0.01 versus SED). However, unlike the observation in the heart, the levels of nitrite and nitrosothiols in the skeletal muscle declined back to near baseline levels at 1 week after the end of the VE period. In contrast, nitrate levels were significantly higher 1 week after the end of VE training (PϽ0.05 versus SED).
Exercise Increases Circulating Levels of Nitrosothiols in Trained Endurance Athletes
Additional studies were also performed to determine whether VE training increased the steady-state levels of NO metabolites in human athletes. Blood samples were taken from individuals who exercised for at least 45 minutes a day, Ͼ3 times a week, for at Ն2 years (trained endurance athletes) and from nontrained individuals. Subject characteristics are shown in Online Table I. Analysis revealed that trained endurance athletes (age 24Ϯ2, nϭ7) and nontrained individuals (age 27Ϯ1, nϭ16) had similar plasma levels of nitrite and nitrate ( Figure 4H ). In contrast, trained endurance athletes were found to have significantly higher (Pϭ0.014) plasma nitrosothiol levels (15Ϯ4 versus 7Ϯ1 nmol/L versus nontrained individuals, Figure 4I ).
VE Increases the Levels of Circulating Catecholamines and Increases the Expression of the ␤ 3 -AR
Recent studies have indicated an upregulation in the density of ␤ 3 -ARs 19 and an increase in ␤ 3 -AR stimulants (ie, catecholamines) 12 in response to exercise training. As shown in Figure 5A , we found that VE significantly (PϽ0.05 versus SED) increased the circulating levels of epinephrine and norepinphrine at the end of the training period. However, both had returned to normal levels 1 week after the end of the training. Furthermore, Western blot analysis revealed ( Figure  5B and 5C) a significant increase in the protein expression of cardiac ␤ 3 -AR in the hearts of the VE 4-week group (PϽ0.05 versus SED), but not in the hearts of the VE 4 weeks ϩ1 week SED group. No changes in the expression of ␤ 1 -AR and ␤ 2 -AR were noted in response to VE training. Given that ␤ 3 -AR stimulation results in the production of NO from eNOS, 20 we next evaluated the role that ␤ 3 -ARs play in mediating the generation of NO metabolites during VE, as well as the role that they play in mediating the cardioprotective effects of VE. First, we examined the effects of VE on eNOS expression and phosphorylation status in mice deficient in ␤ 3 -AR (␤ 3 -AR Ϫ/ Ϫ ). VE training promoted a significant decrease ( Figure 6A and 6B ) in the expression of eNOS-P Ser1177 (PϽ0.05 versus SED), as well as a significant decrease in the expression of nNOS (PϽ0.001 versus SED). No changes in the expression of eNOS, eNOS-P Thr495 , or iNOS were noted. As a result of these alterations, VE failed to increase the plasma or heart levels of nitrite, nitrate, and nitrosothiols in the ␤ 3 -AR Ϫ/ Ϫ mice ( Figure 6C through 6E) . We then evaluated how these alterations would affect VEmediated cardioprotection. Beta 3 -AR Ϫ/ Ϫ mice were subjected to 4 weeks of VE training followed by MI/R ( Figure   6F ). We found that the deficiency of mice did not exercise to the same extent as the C57BL/6J wild-type mice exercised (Online Figure I, PϽ0.001) , suggesting that a deficiency in ␤ 3 -ARs dampens the ability of mice to exercise.
Additional experiments were performed to further demonstrate a relationship between catecholamines and eNOS/NO. For these experiments, we studied the effects of a single injection of epinephrine on eNOS expression and phosphorylation status, as well as the levels of plasma and cardiac NO. Epinephrine dose dependently increased the heart rate and cardiac contractility of mice at concentrations ranging from 0.050 g/kg to 10 g/kg (Online Figure IVA and IVB) . Using the higher dose (10 g/kg), we found that epinephrine increased the expression of eNOS-P Ser1177 in a timedependent manner (Online Figure VA and VB) . No changes in the expression of total eNOS, iNOS, or nNOS were observed. Epinephrine also increased the levels of both nitrite and nitrosothiols in the plasma and heart in a time-dependent manner (Online Figure VI) . These data suggests that ␤-AR stimulation rapidly induces changes in eNOS phosphorylation, resulting in an increase in NO bioavailability.
The Sustained Cardioprotective Effects of VE Are Lost When NO Metabolites Return to Normal Levels
Additional experiments were performed to determine whether the sustained cardioprotective effects of VE were present at a time when NO metabolites had returned to normal levels. For these experiments, mice were allowed to exercise for 1 week and then removed from the cages for a period of either 1 week (VE 1 weekϩ1 week SED) or 4 weeks (VE 1 weekϩ4 weeks SED). Mice in the VE 1 weekϩ1 week SED group displayed a significant increase in the levels of nitrite, nitrate, and nitrosothiols in both the plasma and heart (PϽ0.05 versus SED; Figure 7A through 7C). In contrast, mice in the VE 1 weekϩ4 weeks SED group displayed no changes in plasma or heart NO metabolite levels when compared with SED mice, suggesting that the VE-induced alterations in eNOS/NO had returned to baseline levels 4 weeks after the end of the training period. Additionally, following MI/R, the VE 1 weekϩ1 week SED mice displayed a 31% reduction (PϽ0.05 versus SED; Figure 7D ) in INF in relation to the AAR when compared with the SED control mice. In contrast, the VE 1 weekϩ4 weeks SED mice were not protected against MI/R injury, suggesting that the sustained cardioprotective effects of exercise are lost when NO metabolite levels are not elevated.
Discussion
The endothelium plays a critical role in mediating the protective effects associated with exercise. Specifically, increased vascular wall shear stress induced by exercise increases the expression and activity of vascular eNOS, which subsequently increases the production and bioavailability of NO throughout the body. 21, 22 In the current study, we not only confirmed this finding but also found that exercise altered the expression and phosphorylation status of eNOS in a very tissue-specific manner. In the heart, we found that exercise increased the expression of eNOS-P Ser1177 and decreased the expression of eNOS-P Thr495 without altering the expression of total eNOS, whereas in the skeletal muscle, exercise increased the expression of total eNOS and decreased the expression of eNOS-P Thr495 . Furthermore, the degree to which exercise mediated these changes was also found to be tissue specific, because the alterations observed in the heart persisted for at least 1 week after the end of the training period, whereas those changes observed in the skeletal muscle returned to baseline levels at this time point. This suggests that the mechanism or mechanisms responsible for the alterations in eNOS may also be tissue specific.
Importantly, the observed alterations in eNOS resulted in an increase in NO bioavailability, as evidenced by an increase in the plasma, skeletal muscle, and cardiac levels of nitrite and nitrosothiols. Circulating nitrite and nitrosothiol levels have traditionally been considered an acute marker of NO production and surrogate for endothelial function and cardiovascular health status. 5 As such, their role in mediating the cardioprotective effects of exercise has not been investigated. Given the recent paradigm shift in NO biology, the role of these NO metabolites in exercise should be reconsidered. In the current study, we for the first time provide strong evidence that the generation and storage of nitrite and nitrosothiols plays a role in mediating the acute and sustained cardioprotective effects of exercise. First, we report that 4 weeks of VE training increased the levels of nitrite and nitrosothiols in the plasma, skeletal muscle, and heart in mice. Given that nitrite is reduced to NO during myocardial I/R 8 and that nitrosothiols act as a redox-sensitive NO donor, 23 it can be suggested that some of the acute cardioprotective effects of VE can be attributed to both nitrite and nitrosothiols. Second, we found that nitrite, nitrate, and nitrosothiols were stored in the heart for 1 week after the cessation of VE. Because nitrate can also be reduced to nitrite, which can then subsequently be reduced to NO, 18 it is probable that all 3 of these NO metabolites play a role in mediating the sustained cardioprotective effects of VE. This is further supported by the observation that the cardiac expression of CuZnSOD and AMPK were unchanged when compared with the SED control mice at this same time point. Third, we found that the cardioprotective effects of exercise did not extend to 4 weeks after the cessation of the training period when the levels of nitrite and nitrosothiols in both the plasma and heart had returned to baseline levels. Fourth, we found that nitrosothiol levels were increased in the plasma of trained endurance athletes. Although these data do not offer any insights into storage levels of NO metabolites in the heart, they do provide evidence that VE increases the circulating levels of nitrosothiols in humans and provide a clinical basis to support the experimental findings of the current study.
Accumulating evidence indicates that nitrosothiols (Snitrosothiols in particular) play an important role both in normal physiological processes and in a broad spectrum of human diseases. Nitrosothiols, which are formed by the ubiquitous redox-related modification of cysteine thiols in a process known as nitrosylation, have emerged as the most important mechanisms by which NO imparts its cellular effects. 24 With regard to cardiovascular physiology, protein S-nitrosylation can influence cardiac contractility through the regulation of ␤-AR signaling and calcium cycling. [25] [26] [27] Additionally, increasing the S-nitrosylation of proteins in the heart can reduce I/R injury 8 by preventing the irreversible oxidation of proteins during early reperfusion, 9 by inhibiting apoptosis 28 and inflammation, 29 by influencing blood flow and oxygen delivery, 30 and by modulating angiogenesis. 31 On the basis of this evidence, the findings of the current study suggest that nitrosothiols may be a more significant indicator of NO-mediated protection during exercise when compared with the other NO metabolites, given that both NO and nitrite can covalently modify a reactive cysteine to form a nitrosothiol. 7, 32 Another major finding of the current study relates to the role of ␤ 3 -ARs in exercise. In the heart, 3 populations of ␤-ARs potentially modulate cardiac function (␤ 1 -, ␤ 2 -, and ␤ 3 -AR). 20 These different subtypes belong to the G proteincoupled receptor superfamily and modulate cardiac function after stimulation by catecholamines. 33 The effects of ␤ 1 -and ␤ 2 -AR are well established both in human and other mammals, because their stimulation produces positive chronotropic and inotropic effects. Although the precise physiological and pathophysiological roles of ␤ 3 -ARs remain uncertain, recent observations suggests that ␤ 3 -AR stimulation produces a negative inotropic effect via the production of NO from eNOS. 20 The activation of eNOS during exercise can be caused by shear stress, inducing a signaling cascade involving Akt (protein kinase B), protein kinase A (PKA), or AMPK. 34, 35 A recent study reported that inhibition of Akt signaling with wortmannin blunts the increase in the vascular expression of eNOS-P Ser1177 in mice subjected to treadmill running without altering the expression of phosphorylated CREB (PKA signaling) or AMPK. 34 Because wortmannin did not completely attenuate the increase in the expression of eNOS-P Ser1177 , these data simply suggest that Akt plays a major role in regulating this phosphorylation. This also suggests that other signaling molecules regulate the expression of eNOS-P Ser1177 during exercise.
Here, we provide strong evidence that ␤ 3 -ARs are involved in this process. First, in agreement with other studies, 12 we found that 4 weeks of VE significantly increased the circulating levels of epinephrine and norepinephrine, as well as the protein expression of cardiac ␤ 3 -ARs. Previously in cultured cells, it has been reported that epinephrine can rapidly increase the expression of eNOS-P Ser1177 in a ␤ 3 -ARdependent manner. 36 We also found that acute injections of epinephrine rapidly increased the expression of eNOS-P Ser1177 and the levels of NO metabolites in both the plasma and heart. Although these studies do not provide direct evidence that ␤ 3 -AR stimulation can increase the expression of eNOS-P Ser1177 , it does suggest that epinephrine can modulate eNOS/NO levels in vivo. However, a direct relationship was demonstrated with our studies using ␤ 3 -AR-deficient mice. On the basis of the existing literature, we predicted that a deficiency in ␤ 3 -ARs would dampen the increase in the expression of eNOS-P Ser1177 in response to exercise in a similar manner as that reported for wortmannin. Interestingly, we found that in response to exercise, the increase in the expression of eNOS-P Ser1177 was not simply blunted in the hearts of ␤ 3 -AR-deficient mice, but rather its expression was significantly decreased when compared with sedentary control levels. Additionally, exercise induced a significant decline in the expression of nNOS in the hearts of ␤ 3 -AR deficient mice. This was also a rather surprising finding, given that nNOS levels did not change in the hearts of wild-type mice that exercised but supportive of the recent evidence indicating that ␤ 3 -AR stimulation can also regulate nNOS. 11 As a result of this downregulation, exercise failed to increase the plasma or heart levels of nitrite, nitrate, and nitrosothiols in the ␤ 3 -AR Ϫ/ Ϫ mice. Importantly, in response to exercise, a deficiency of ␤ 3 -ARs leads to an exacerbation of myocardial infarction following ischemia-reperfusion injury. Taken together, these results suggest that ␤ 3 -ARs not only play a major role in regulating the phosphorylation of eNOS at serine 1177, as well as maintaining the basal expression of myocardial nNOS during exercise, but also are necessary for regulating the production of NO during exercise and for mediating the cardioprotective effects of exercise.
Although it is not fully known how ␤ 3 -ARs regulate the expression of eNOS, it is known that interfering with this regulation can lead to detrimental effects. Previously, it has been reported that lack of ␤ 3 -AR signaling exacerbates cardiac pressure-overload-induced remodeling by enhancing eNOS uncoupling and increasing superoxide production. 37 It is currently unknown whether exercise causes eNOS to become uncoupled in the hearts of ␤ 3 -AR Ϫ/ Ϫ . However, the uncoupling of eNOS would certainly provide an explanation as to why the ␤ 3 -AR Ϫ/ Ϫ mice in the current study displayed exacerbated myocardial injury following exercise training. This would also, in part, explain the different response to MI/R injury between the eNOS Ϫ/ Ϫ and ␤ 3 -AR Ϫ/ Ϫ mice, given that the eNOS Ϫ/ Ϫ could not experience eNOS uncoupling and subsequent superoxide production.
In summary, the current study demonstrates that 4 weeks of VE training provides acute and sustained cardioprotection against MI/R injury. Additionally, the current study provides evidence that NO metabolites play a major role in the observed sustained cardioprotective effects and provides novel evidence suggesting a role for ␤ 3 -ARs in exercisemediated cardioprotection. On the basis of these results, we propose that during exercise sympathetic stimulation via the ␤ 3 -AR leads to the activation of eNOS, resulting in an increase in the production of NO. The NO generated would then have 2 fates. It can either be used to induce vasodilatation 38 to match blood flow to metabolic demands 39 or be metabolized into nitrite and nitrosothiols, which can then be stored in the heart and circulation. This can continue with each passing exercise period until the steady-state levels of the metabolites in the heart are elevated above normal baseline levels. This would be analogous to the effects of oral nitrite supplementation on the heart that was observed in a previous study. 8 Increasing these stores in the heart prior to myocardial ischemia is important because the bioavailability of NO is decreased during ischemia. The cause of this decrease is still not completely understood, but it has been suggested that NO levels are reduced during myocardial ischemia due to a decrease in production from eNOS because of low oxygen and diminished substrate delivery or an increase in ROS production. 6, 40 In any event, the stored nitrite
